Cargando…
The Risk‐Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet
Carriers of germline mutations in genes associated with Lynch syndrome are at increased risk for colorectal, endometrial, ovarian, and other cancers. There is evidence that daily consumption of aspirin may reduce cancer risk in these individuals. There is a need for educational resources to inform c...
Autores principales: | Kaur, Rajneesh, McDonald, Cassandra, Meiser, Bettina, Macrae, Finlay, Smith, Sian K, Kang, Yoon Jung, Caruana, Michael, Mitchell, Gillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744515/ https://www.ncbi.nlm.nih.gov/pubmed/36618023 http://dx.doi.org/10.1002/ggn2.202100046 |
Ejemplares similares
-
The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome
por: Kang, Yoon‐Jung, et al.
Publicado: (2019) -
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey
por: Smith, Samuel G., et al.
Publicado: (2017) -
Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice
por: Meiser, Bettina, et al.
Publicado: (2021) -
Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome
por: Beck,, Sarah Leilani
Publicado: (2012) -
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review
por: Lim, Natalie, et al.
Publicado: (2022)